(Q51791215)

12 April 2018

title

Mast cells in innate and adaptive immunity to infection. (English)

1 reference

12 April 2018

0 references

Thomas J Palker

1

1 reference

12 April 2018

Gang Dong

series ordinal

2

1 reference

12 April 2018

Wolfgang W Leitner

series ordinal

3

1 reference

12 April 2018

language of work or name

English

0 references

publication date

1 January 2010

1 reference

12 April 2018

European Journal of Immunology

published in

1 reference

12 April 2018

volume

40

1 reference

12 April 2018

issue

1

1 reference

12 April 2018

page(s)

13-18

1 reference

12 April 2018

Human mast cells undergo TRAIL-induced apoptosis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

TLR2-dependent mast cell activation contributes to the control of Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Our perception of the mast cell from Paul Ehrlich to now.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Human tissue mast cells are an inducible reservoir of persistent HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

The alliance of sphingosine-1-phosphate and its receptors in immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Environmental epigenomics and disease susceptibility

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Prevention of lipopolysaccharide-induced microangiopathy by gp49B1: evidence for an important role for gp49B1 expression on neutrophils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Are we ready to downregulate mast cells?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

P2Y6 receptors require an intact cysteinyl leukotriene synthetic and signaling system to induce survival and activation of mast cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Evaluation of the substrate specificity of human mast cell tryptase beta I and demonstration of its importance in bacterial infections of the lung

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Alpha-4 integrins and VCAM-1, but not MAdCAM-1, are essential for recruitment of mast cell progenitors to the inflamed lung

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Immunomodulatory mast cells: negative, as well as positive, regulators of immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

New developments in mast cell biology

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Mast cell activators: a new class of highly effective vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200990325

7 January 2021

Identifiers

DOI

10.1002/EJI.200990325

1 reference

12 April 2018

PubMed ID

20043290

1 reference

12 April 2018